Causaly vs PostEra
CausalyDrug Discovery Platforms
CustomPublished price
PostEraDrug Discovery Platforms
CustomPublished price
Causaly Drug Discovery Platforms Unlock R&D decision velocity with the Agentic AI platform for life sciences | PostEra Drug Discovery Platforms Medicinal Chemistry Powered by Machine Learning | |
|---|---|---|
| Overview | ||
| Category | Drug Discovery Platforms | Drug Discovery Platforms |
| What it is | AI-powered biomedical research platform extracting causal relationships from scientific literature for pharma. | AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis. |
| Pricing | ||
| Published price | Custom Enterprise life-sciences AI platform sold via sales contact; no public pricing. Priced per organization/seat and scope; customers include 12 of the top 20 pharma companies. | Custom No public pricing; partnership/collaboration-based. PostEra engages pharma partners under drug-discovery deals (with Pfizer, Amgen and others) rather than a self-serve subscriptio… |
| Pricing model | Custom quote | Custom quote |
| Free options | No free plan · No free trial | No free plan · No free trial |
| Deal on Cubbie | None right now | None right now |
| Company | ||
| Founded | 2015 | 2019 |
| Team size | 51-200 employees | 51-200 employees |
| Headquarters | London, UK | Boston, MA |